Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0214821. doi: 10.1128/aac.02148-21. Epub 2022 Jan 31.
Direct antimicrobial susceptibility testing (AST) of positive blood cultures with Gram-negative bacteria produces results within 24 h, compared to 48 to 96 h with conventional methods. Positive clinical blood cultures were studied, supplemented with contrived blood cultures inoculated with a spectrum of resistant isolates. Bacterial inocula used for direct AST were quantitated. Direct AST was performed using MicroScan NM43 trays inoculated directly from positive blood cultures (100 μL in 25 mL water) and incubated using a WalkAway instrument, with trays read after 16 h. Reference AST was performed the following day from growth on solid medium using the same trays. Agreement of AST results between direct and reference methods, with and without the use of three expert rules for β-lactams, was evaluated using FDA categorical agreement criteria. Of 86 specimens tested (41 clinical specimens and 45 contrived specimens), the mean bacterial load in positive blood cultures was 8.98 log CFU/mL. Fifteen isolates contained extended-spectrum β-lactamases, and 27 contained carbapenemases. Of 1,985 pairs of AST categorical results for 25 antimicrobials, 55.0% were susceptible, 4.7% intermediate, and 40.4% resistant by reference testing. Overall categorical agreement was 92.3%, with 5.3% minor errors, 1.9% major errors, and 0.4% very major errors. Agreement was higher for non-β-lactam agents (95.8%) than for β-lactam agents (90.3%; < 0.0001). Application of expert rules increased agreement for β-lactam agents to 94.6%. The methods used achieved the study goal of producing accurate, cost-effective AST results directly from positive blood cultures using MicroScan trays with a 16-h incubation time without the need for additional testing. Use of three expert β-lactam rules improved accuracy.
直接药敏试验(AST)对革兰氏阴性菌阳性血培养物的检测结果可在 24 小时内获得,而传统方法则需要 48 至 96 小时。研究了阳性临床血培养物,并补充了接种有一系列耐药分离株的人工血培养物。用于直接 AST 的细菌接种物进行了定量。直接 AST 使用 MicroScan NM43 托盘直接从阳性血培养物(25ml 水中 100μl)进行接种,并使用 WalkAway 仪器孵育,孵育 16 小时后读取托盘。第二天从固体培养基上的生长物使用相同的托盘进行参考 AST。使用 FDA 分类协议标准评估直接和参考方法(使用和不使用三种β-内酰胺专家规则)AST 结果的一致性。在 86 个测试样本(41 个临床样本和 45 个人工样本)中,阳性血培养物中的细菌负荷平均值为 8.98 log CFU/ml。15 个分离株含有超广谱β-内酰胺酶,27 个分离株含有碳青霉烯酶。对于 25 种抗菌药物的 1985 对 AST 分类结果,参考测试的 55.0%为敏感,4.7%为中介,40.4%为耐药。总体分类一致性为 92.3%,5.3%为次要错误,1.9%为主要错误,0.4%为非常大错误。非β-内酰胺药物的一致性(95.8%)高于β-内酰胺药物(90.3%;<0.0001)。应用专家规则使β-内酰胺药物的一致性提高到 94.6%。使用 MicroScan 托盘和 16 小时孵育时间,无需额外测试,直接从阳性血培养物获得准确、具有成本效益的 AST 结果,达到了研究目标。使用三种专家β-内酰胺规则可提高准确性。